Providing market intelligence for more than 35 years

In The News

Competition, Consolidation, And… Cosmo? A Look At OTT's Year To Come

Parks Associates Director of Research Brett Sappington told FierceOnlineVideo that the content issue means that OTT will continue to see a lot of churn in 2016 as consumers "stack" services, adding and dropping SVOD (subscription video on demand) or AVOD (ad-supported video on demand) services to get the lineup they want. "Right now we're seeing most people take Netflix and then kind of add to that, and churn through some other services to find the mix of services that they want. What we're not sure of yet is, are they switching these other services because they've burned through all this content and are looking for something new, or are they just experimenting as they try to figure out what are their favorites?"

From the article "Competition, Consolidation, And… Cosmo? A Look At OTT's Year To Come" by Samantha Bookman.

Previously In The News

15 Percent of U.S. Broadband Households Plan to Buy Wireless Speakers

A recent Parks Research study found that, of U.S. broadband households, 18 percent plan to buy earbuds over the next 12 months, 16 percent plan to buy headphones, and 15 percent plan to buy wireless s...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...